Deoxyuridine



Compound IDCDAMM02512
Common nameDeoxyuridine
IUPAC name1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Molecular formulaC9H12N2O5

Experimental data

Retention time10.71
Adduct[M+H]+
Actual mz229.081
Theoretical mz229.082
Error3.39
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score8.5872

Identifiers and class information

Inchi keyMXHRCPNRJAMMIM-SHYZEUOFSA-N
SmilesO=C1C=CN(C(=O)N1)C2OC(CO)C(O)C2
SuperclassNucleosides, nucleotides, and analogues
ClassPyrimidine nucleosides

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)3
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)228.204
Computed dipole moment(dipole)6.152
Total solvent accessible surface area (SASA)404.953
Hydrophobic component of SASA (FOSA)131.253
Hydrophilic component of SASA (FISA)216.42
Pie component of the SASA (PISA)57.28
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)678.51
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)8.6
Free energy of solvation of dipole (dip^2/V)0.055772
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0367836
Globularity descriptor (glob)0.922142
Predicted polarizability in cubic angstroms (QPpolrz)19.621
Predicted hexadecane/gas partition coefficient (QPlogPC16)7.397
Predicted octanol/gas partition coefficient (QPlogPoct)16.147
Predicted water/gas partition coefficient (QPlogPw)14.758
Predicted octanol/water partition coefficient (QPlogPo/w)-1.165
Predicted aqueous solubility (QPlogS)-1.372
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.314
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.065
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)87.82
Predicted brain/blood partition coefficient (QPlogBB)-1.314
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)35.686
Predicted skin permeability, log Kp (QPlogKp)-5.018
PM3 calculated ionization potential (IP(ev))9.724
PM3 calculated electron affinity (EA(eV))0.458
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-0.799
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)54.909
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)125.503
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P04818TYMSThymidylate synthase (by homology)T98397SEA
P04183TK1Thymidine kinase, cytosolicT30081SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P32320CDACytidine deaminase (by homology)T79027SEA
P19971TYMPThymidine phosphorylaseT59929SEA
P41231P2RY2Purinergic receptor P2Y2T93515SEA
Q15077P2RY6Pyrimidinergic receptor P2Y6T90782SEA
P23919DTYMKThymidylate kinaseT94400SEA
O00142TK2Thymidine kinase, mitochondrialT22976SEA
Q15391P2RY14Purinergic receptor P2Y14T16555SEA
P28340POLD1DNA polymerase delta subunit 1T02258SEA
Q96SW2CRBNProtein cereblonT27861SEA
Q13304GPR17Uracil nucleotide/cysteinyl leukotriene receptorT33902SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T98397DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P04818TYMS
T98397DI0395Stomach cancer[ICD-11: 2B72]P04818TYMS
T30081DI0012Acute myeloid leukaemia[ICD-11: 2A60]P04183TK1
T30081DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]P04183TK1
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T79027DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P32320CDA
T59929DI0117Depression[ICD-11: 6A70-6A7Z]P19971TYMP
T93515DI0436Visual system disease[ICD-11: 9E1Z]P41231P2RY2
T90782DI0025Alzheimer disease[ICD-11: 8A20]Q15077P2RY6
T22976DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]O00142TK2
T02258DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P28340POLD1
T27861DI0060Brain cancer[ICD-11: 2A00]Q96SW2CRBN
T27861DI0123Diffuse large B-cell lymphoma[ICD-11: 2A81]Q96SW2CRBN
T27861DI0235Liver cancer[ICD-11: 2C12]Q96SW2CRBN
T27861DI0239Lupus erythematosus[ICD-11: 4A40]Q96SW2CRBN
T27861DI0241Lymphoma[ICD-11: 2A80-2A86]Q96SW2CRBN
T27861DI0249Mature B-cell leukaemia[ICD-11: 2A82]Q96SW2CRBN
T27861DI0274Multiple myeloma[ICD-11: 2A83]Q96SW2CRBN
T27861DI0368Sarcoidosis[ICD-11: 4B20]Q96SW2CRBN
T27861DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q96SW2CRBN

Copyright © 2025